You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 6, June 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Response to Levodopa Treatment in Dopa-Responsive Dystonia

John G. Nutt, MD; Torbjoern G. Nygaard, MD

Arch Neurol. 2001;58:905-910.

Background  Dopa-responsive dystonia (DRD) is similar to Parkinson disease in that both disorders have impaired dopamine synthesis and respond to levodopa treatment. Dopa-responsive dystonia differs in that dopamine storage is intact in contrast to Parkinson disease in which it is markedly reduced.

Objective  To examine the short- and long-duration responses to levodopa dosing in subjects with DRD.

Methods  The response to brief infusions of levodopa was examined in 4 subjects with DRD and the effects of withdrawal of levodopa for 3 to 7 days studied in the 3 subjects receiving long-term levodopa therapy. Motor function was measured with tapping speed, Unified Parkinson's Disease Rating Scale motor score, and global dystonia score.

Results  The short-duration response to levodopa dosing seems to develop more slowly and persists longer in subjects with DRD than in subjects with Parkinson disease. Withdrawal of levodopa leads to a gradual decline in tapping speed and reemergence of dystonia over several days, similar to the rate of decay of motor function in Parkinson disease. The short- and long-duration responses were not clearly differentiated in DRD.

Conclusions  This pilot study suggests that retained dopamine storage in DRD may prolong the short-duration response and blur the distinction of the short- and long-duration responses. The decline in motor function in DRD on withdrawal of long-term levodopa therapy resembles that in Parkinson disease, suggesting that a long-duration response, if it exists in DRD, is unrelated to dopamine storage.


From the Departments of Neurology and Physiology and Pharmacology, Oregon Health Sciences University, Portland (Dr Nutt); Department of Neurology, East Orange Veterans Affairs Medical Center, East Orange, NJ (Dr Nygaard); and the Department of Neurosciences, University of Medicine and Dentistry–New Jersey Medical School, Newark, NJ (Dr Nygaard).

Corresponding author: John G. Nutt, MD, Department of Neurology, OP 32, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR 97201-3098.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(6):1028-1029.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intracortical inhibition of the motor cortex in Segawa disease (DYT5)
Hanajima et al.
Neurology 2007;68:1039-1044.
ABSTRACT | FULL TEXT  

Broadening the Phenotype of Childhood-Onset Dopa-Responsive Dystonia.
Chaila et al.
Arch Neurol 2006;63:1185-1188.
ABSTRACT | FULL TEXT  

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Wider et al.
Arch Neurol 2006;63:951-955.
ABSTRACT | FULL TEXT  

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
de la Fuente-Fernandez et al.
Brain 2004;127:888-899.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.